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tion than glomerulonephritis in relation to WG. This differenceRenal histology in ANCA-associated vasculitis: Differences
may be due to a delayed establishment of diagnosis in patientsbetween diagnostic and serologic subgroups.
with MPA compared to patients with WG. Both active andBackground. Differences in renal histopathology between
chronic lesions are more abundantly present in MPO-ANCA–microscopic polyangiitis (MPA) and Wegener’s granulomato-
positive patients than in patients with PR3-ANCA–positivity,sis (WG), and between anti-neutrophil cytoplasm autoantibody
which suggests that the pathogenesis of renal disease in these(ANCA) test results in patients with ANCA-associated vasculi-
ANCA subsets could be different. Our results also suggesttis may provide insight into the differences in pathogenesis
that ANCA test results may be useful in classifying ANCA-and raise the opportunity of classifying the vasculitides more
associated vasculitides.accurately. The possible differences in histopathology are in-
vestigated in this study.
Methods. We report an analysis of 173 patients with renal
disease in microscopic polyangiitis or Wegener’s granulomato- Rapidly progressive deterioration of renal functionsis. A total of 173 renal biopsies, performed at diagnosis, were
is a frequent but clinically unfavorable feature of anti-scored by two observers separately, using a previously stan-
neutrophil cytoplasm autoantibody (ANCA)-associateddardized protocol. Consensus on each biopsy was achieved
during a central review. vasculitis, including microscopic polyangiitis, Wegener’s
Results. Normal glomeruli were more common in WG than granulomatosis, and renal limited vasculitis [1]. Usually,
in MPA (P  0.001). Glomerulosclerosis was more prominent this rapidly progressive deterioration of renal functionin MPA than in WG (P  0.003). Interstitial fibrosis (P 
is histopathologically accompanied by a pauci-immune0.001), tubular atrophy (P  0.001), and tubular casts (P 
crescentic necrotizing glomerulonephritis. However, the0.005) were more frequently present and more severe in MPA
than in WG. Presence of glomerulosclerosis was more extensive histopathological features vary among patients from mild
in patients with myeloperoxidase (MPO)-ANCA than with focal segmental extracapillary proliferation to diffuse
proteinase 3 (PR3)-ANCA (P  0.022). Interstitial fibrosis crescentic necrotizing glomerulonephritis with granulo-(P 0.008), tubular necrosis (P 0.030), tubular atrophy (P
mas and tubular intra-epithelial infiltrates. In some cases,0.013), and intra-epithelial infiltrates (P  0.006) were more
extensive glomerulosclerosis is found [2].frequently present and more severe in MPO-ANCA than in
PR3-ANCA. The differences between microscopic polyangiitis and
Conclusions. Glomerulonephritis in relation to MPA has Wegener’s granulomatosis have been described as fol-
more characteristics of chronic injury at the time of presenta- lows [3, 4]. Microscopic polyangiitis is characterized by
a non-granulomatous systemic vasculitis that is associ-
1 A complete list of EUVAS participants is in the Acknowledgments. ated, in a majority of cases, with ANCA positivity in a
cytoplasmic (C-ANCA,25%) or perinuclear (P-ANCA,Key words: renal biopsy, glomerulonephritis, microscopic polyangiitis,
60%) staining pattern, as determined by indirect im-Wegener’s granulomatosis, renal limited vasculitis, ANCA-associated
vasculitis. munofluorescence [5]. Sera that produce the C-ANCA
pattern nearly always react with proteinase-3 (PR3-Received for publication June 8, 2001
ANCA). The major P-ANCA target is myeloperoxidaseand in revised form July 31, 2001
Accepted for publication August 1, 2001 (MPO-ANCA). Wegener’s granulomatosis is character-
ized by a granulomatous systemic vasculitis with upper 2002 by the International Society of Nephrology
80
EUVAS: Renal histology in vasculitis 81
Table 2. Inclusion criteria for MEPEX (1, 2 and 3 are required)Table 1. Inclusion criteria for CYCAZAREM
(1, 2 and 3 are required)
1. A diagnosis of new or previously untreated MPA, RLV, or WG
with active vasculitis, as indicated by the presence of active1. A diagnosis of new or previously untreated MPA, RLV,
or WG with or without histological confirmation. necrotizing glomerulonephritis on renal biopsy.
2. ANCA-positivity; that is, one of the following possibilities:2. Either Renal involvement attributable to active MPA,
RLV, or WG with one or more of: 1) C-ANCA
2) PR3-ANCA1) Elevated serum creatinine
2) Hematuria (30 red blood cells per high power 3) MPO-ANCA
ANCA-negativity is allowed if the disease is confirmed histologicallyfield)
3) Red cell casts 3. Biopsy-proven necrotizing and/or crescentic glomerulonephritis, in
the absence of another defined glomerulopathy, with severe renal4) Proteinuria (1 gram/24 h)
And/or Other severe organ involvement or imminent loss of vital impairment; that is, one of the following possibilities:
1) Oliguria (400 mL/24 h)organ function, attributable to active MPA or WG.
3. ANCA-positivity; that is, one of the following 2) Intention to commence dialysis within 48 hours of admission
3) Creatinine 500 mol/Lpossibilities:
1) C-ANCA
2) PR3-ANCA
3) MPO-ANCA
ANCA-negativity is allowed if the disease is confirmed
conditions enabled us to perform the present study inhistologically.
which we determined (1) differences in the occurrenceAbbreviations are in the Appendix.
of renal histological lesions between microscopic polyan-
giitis, Wegener’s granulomatosis, and renal limited vas-
culitis; and (2) differences in the occurrence of renal histo-
logical lesions between patients with ANCA-associatedairway involvement that is associated, in a majority of
vasculitis with various ANCA test results.cases, with C-ANCA positivity (65%) in the presence
of PR3-ANCA, or P-ANCA positivity (20%) in the
presence of MPO-ANCA [5]. Renal limited vasculitis is METHODS
distinguished from microscopic polyangiitis and Wegen-
Patientser’s granulomatosis by the absence of extrarenal symp-
Patients in the present study were derived from two oftoms of vasculitis. Despite these relatively clear disease
the first-wave trials of the EUVAS [10]: CYCAZAREM,descriptions, a diagnosis for the individual patient may
a randomized trial of cyclophosphamide versus azathio-be difficult to establish in clinical practice. Currently,
prine during remission of ANCA-positive systemic vascu-patients are treated similarly, irrespective of their diag-
litis [10], and MEPEX, a randomized trial of adjunctivenosis. Whether diagnosis-specific modulation of therapy
therapy for severe glomerulonephritis in ANCA-associ-is needed, is unclear. This issue needs to be addressed.
ated systemic vasculitis that examined plasma exchangeKnowledge of the differences in renal histopathology
versus intravenous administration of methylpredniso-between these three diseases is relatively limited, though
lone [10]. Patients only were included into the presentdistinct differences may help to establish a more certain
study if a renal biopsy, performed at study entry, was avail-diagnosis and may give insight into the pathogenesis of
able. Inclusion criteria for CYCAZAREM and MEPEX
ANCA-associated systemic vasculitis.
are listed in Tables 1 and 2, respectively. Exclusion crite-
Clinically, vasculitic syndromes overlap, and diagnoses ria for both trials included age under 18, pregnancy, pre-
sometimes may be uncertain. Therefore, differentiation vious malignancy, known HIV positivity, administration
between the vasculitic syndromes by means of ANCA of any cytotoxic drug within a year before entry, and hep-
test results is sometimes preferred, which may be sup- atitis B antigenemia (only if HepB-ag positive). An addi-
ported by the possible pathogenic role of ANCAs in tional exclusion criterion for CYCAZAREM was serum
pauci-immune crescentic necrotizing glomerulonephritis creatinine500 mol/L. Additional exclusion criteria for
in relation to ANCA-associated vasculitis, and by the MEPEX were serum creatinine500 mol/L, life-threat-
observation that meaningful differences between pa- ening non-renal manifestations of vasculitis, including
tients with various ANCA test results exist [6]. Differ- alveolar hemorrhage requiring mechanical ventilation
ences in renal histopathology between patients with dif- within 24 hours of admission, on dialysis for more than
ferent ANCA test results were investigated but led to two weeks prior to referral, significant baseline renal im-
contradictory results (abstract, Bajema IM, J Am Soc pairment (creatinine 200 mol/L, one year or more be-
Nephrol 8:532A, 1997) [7–9]. fore presentation), or a previous episode of biopsy-proven
Within the framework of the European Vasculitis Study necrotizing and/or crescentic glomerulonephritis [10].
group (EUVAS; see Acknowledgments), we prospec-
Renal histopathologytively gathered renal biopsies with clinical information
of a large and homogeneous group of patients with renal Paraffin sections were stained with silver, periodic
acid-Schiff (PAS), hematoxylin & eosin (H&E), and tri-disease in relation to ANCA-associated vasculitis. These
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chrome, and were forwarded to two of five participating ANCA, respectively. To determine the different patterns
of renal lesions in ANCA test subgroups, the ANCApathologists (IMB, LHN, FF, RW, JAB). Both patholo-
gists scored the biopsies separately, blinded to patient test results also were classified as a combination of the
IIF and ELISA results, as the specificity of ANCA testingdata and the scores of the other observer, and according
to a previously standardized protocol for scoring renal increases by using this combination, compared to IIF or
ELISA alone [5].biopsies of patients with ANCA-associated systemic vas-
culitis [11, 12]. In short, each glomerulus had to be scored
Statisticsseparately on the presence of fibrinoid necrosis, crescents
(cellular/fibrous and segmental/circumferential), glomer- Differences of quantitative parameters between groups
were assessed with the t test for independent samples.ulosclerosis (local/segmental/global), periglomerular in-
filtrates, granulomatous reactions, as well as a number Differences of semiquantitative results were tested by
using the Mann-Whitney U test. Difference of genderof other lesions. The presence of glomerular lesions was
calculated as the percentage of the total number of glo- between groups was analyzed by the chi-square test.
meruli in a biopsy. Most interstitial, tubular and vascular
lesions were scored as present or absent, except for inter-
RESULTS
stitial infiltrates (///), interstitial fibrosis
Patients(//) and tubular atrophy (//), which were
scored semiquantitatively. Together, 39 histological pa- Renal biopsies were performed in 132 of 157 patients
that were recruited in CYCAZAREM. As a renal bi-rameters were examined. The scores were entered into a
central database (MSAccess) and discrepancies between opsy was an inclusion criterion for MEPEX, a renal
biopsy was performed in all 124 patients in this study.the observers were resolved by conference during central
reviews, achieving consensus for each biopsy. Of the combined 256 biopsies from these two studies,
180 were received for re-evaluation. Seven of these 180Immunofluorescence for immunoglobulins and com-
plement components, and electron microscopy were per- biopsies were excluded: five biopsies because of the ab-
sence of cortical tissue, and two because patients ap-formed locally in all participating centers. For logistical
reasons, these procedures were not standardized or re- peared to have antibodies directed against the glomeru-
lar basement membrane. Together, 173 biopsies (98 fromviewed by the EUVAS, but the local conclusions were
reported. CYCAZAREM and 75 from MEPEX) were available
for evaluation in the present study. Patient diagnoses
Diagnosis (as defined in the Methods section) were microscopic
polyangiitis (N  80), renal limited vasculitis (N  19),Meeting the inclusion criteria was needed to enter
patients in either CYCAZAREM or MEPEX. Diagnos- and Wegener’s granulomatosis (N  73). The diagnosis
of one patient remained uncertain (doubt about whethertic categories were distinguished (always with respect to
the inclusion criteria, Tables 1 and 2) by the following extrarenal manifestations were attributable to vasculi-
tis). ANCA test results are listed in Table 3. The meancriteria [10] and as such determined by the local physi-
cians, without review by the EUVAS: age of all patients was 59 years (range 21 to 83 years).
Patients with MPO-ANCA were older than patients with
PR3-ANCA (63 vs. 58 years, P  0.033). Patients in-• Microscopic polyangiitis: Systemic vasculitis, pre-
dominantly affecting small vessels, with extrarenal cluded 56% females and 44% males. The gender distri-
bution was comparable in the various groups. Mean se-symptoms, but without airway symptoms compati-
ble with Wegener’s granulomatosis. rum creatinine and GFR of all patients were 453 mol/L
and 31 mL/min, respectively. Patients with microscopic• Renal limited vasculitis: Idiopathic rapidly progres-
sive glomerulonephritis without systemic disease polyangiitis and renal limited vasculitis had a signifi-
cantly lower mean GFR than patients with Wegener’smanifestations.
• Wegener’s granulomatosis: Inflammation of the re- granulomatosis (20 and 22 vs. 44 mL/min, P  0.001).
Patients with a P-ANCA IIF had a significantly lowerspiratory tract together with necrotizing vasculitis
affecting small- to medium-sized vessels. mean GFR than patients with a C-ANCA IIF (21 vs.
40 mL/min, P  0.001). Patients with MPO-ANCA had
ANCA testing a significantly lower mean GFR than patients with
PR3-ANCA (21 vs. 38 mL/min, P  0.002).Indirect immunofluorescence (IIF) and ELISA were
performed for local ANCA testing in all participating
Histological diagnosescenters. The staining pattern in the IIF test was scored
as perinuclear (P-ANCA), cytoplasmic (C-ANCA), atypi- Figure 1 shows the histopathological diagnoses on the
basis of the renal biopsy findings. Crescentic necrotizingcal, or negative. Sera positive for ANCA directed against
MPO and PR3 were reported as MPO-ANCA and PR3- glomerulonephritis was observed in 112 biopsies (65%);
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Table 3. ANCA test results of biopsies and in approximately one third of those cases
was scored as diffuse (). Tubular intra-epithelial in-Diagnosis N
filtrates were seen in 64% of biopsies. Interstitial vasculi-IIF ELISA MPA RLV WG Uncertain
tis was present in only 12% of biopsies. Arteriosclerosis
P-ANCA MPO-ANCA 35 11 9 0
and arteriolosclerosis were present in 70% and 32% ofPR3-ANCA 1 0 0 0
MPO-ANCA & PR3-ANCA 2 0 0 0 biopsies, respectively. Pauci-immunity was concluded in
Negative 5 0 0 0 all patients. Electron microscopy was performed in some
Not reported 5 2 1 0
patients, but histopathological conclusions remained un-C-ANCA MPO-ANCA 0 0 0 0
PR3-ANCA 17 2 40 0 changed with this procedure.
MPO-ANCA & PR3-ANCA 0 0 2 0
Negative 2 0 4 0 Differences between diagnoses
Not reported 5 1 6 0
Atypical ANCA MPO-ANCA 1 0 0 0 Table 4 shows the mean percentage of the main glo-
PR3-ANCA 0 0 0 0 merular parameters in microscopic polyangiitis, renal
MPO-ANCA & PR3-ANCA 0 0 0 0
limited vasculitis, and Wegener’s granulomatosis. In mi-Negative 0 0 0 0
Not reported 0 0 0 0 croscopic polyangiitis, 21% of glomeruli per biopsy were
Negative MPO-ANCA 0 0 0 0 normal, whereas in Wegener’s granulomatosis 40% of
PR3-ANCA 0 0 0 0
glomeruli were normal (Fig. 2A, P 0.001). Glomerulo-MPO-ANCA & PR3-ANCA 0 0 0 0
Negative 1 1 1 0 sclerosis was present in 30% of patients who were diag-
Not reported 1 0 2 0 nosed with microscopic polyangiitis versus only 16% of
Not reported MPO-ANCA 0 1 1 0
patients with Wegener’s granulomatosis (Fig. 2A, P PR3-ANCA 0 0 3 0
MPO-ANCA & PR3-ANCA 0 0 1 0 0.002). The percentage of glomeruli with fibrinoid necro-
Negative 1 0 0 0 sis or crescents did not distinguish between the diagnoses.
Not reported 4 1 3 1
In microscopic polyangiitis, interstitial fibrosis (Fig. 2B)
Abbreviations are in the Appendix.
and tubular atrophy (Fig. 2C) were more frequently and
severely present than in Wegener’s granulomatosis (P
0.001 for both differences). Interstitial infiltrates (Fig.
2D) and tubular necrosis (Fig. 2E) tended to occur morecrescentic glomerulonephritis without fibrinoid necrosis
was present in 40 cases (23%). Two biopsies showed frequently in microscopic polyangiitis than in Wegener’s
granulomatosis (P  0.030 and P  0.035, respectively).interstitial vasculitis only, one biopsy was normal, and
nine biopsies (5%) showed diffuse global glomeruloscle- Tubular casts were more often reported in microscopic
polyangiitis than in Wegener’s granulomatosis (P 0.005).rosis. Other biopsies included focal global glomeruloscle-
rosis, interstitial fibrosis, and mesangial matrix increase. However, there were no differences in proteinuria be-
tween the diagnostic groups (data not shown). Arterio-
Histological parameters in all patients sclerosis was present more often in microscopic polyangi-
itis than in Wegener’s granulomatosis (P  0.021). NoThe histological findings in the entire patient cohort
showed that a mean of 29% of glomeruli per biopsy were difference was observed in the occurrence of interstitial
vasculitis. Biopsies from the 19 patients with renal lim-normal, 45% of glomeruli had (predominantly cellular)
crescents, and 23% were globally sclerotic. Fibrinoid ne- ited vasculitis were more or less comparable to those
from the patients with microscopic polyangiitis (Table 4crosis of the glomerular tuft was present in 22% of glo-
meruli. In five biopsies fibrinoid necrosis was present and Fig. 2).
in glomeruli without crescents, although crescents were
Differences between MPO-ANCA and PR3-ANCAfound in other glomeruli in the same biopsy. Interstitial
edema was present in 34% of biopsies. Interstitial infil- The distribution of histological parameters among the
ELISA test result groups is presented in Table 5. Thetrates were present in 92% of biopsies; in half of those
scored as mild (), in the other half as severe (). mean percentage glomerulosclerosis was 15% in patients
with PR3-ANCA, 25% in patients with MPO-ANCA,Mononuclear inflammatory cells were always present,
and usually, they formed the predominant part of the and 35% in patients with negative ELISA test results
(P  0.022 for the difference between PR3-ANCA andinfiltrates. Neutrophils were present in 65% of biopsies,
but predominant in only a few cases. Although eosino- MPO-ANCA, P 0.005 for the difference between neg-
ative test results and PR3-ANCA; Fig. 3A). The occur-phils were seen in 22% of biopsies, they were never
scored as predominant. Interstitial fibrosis was present rence of fibrinoid necrosis and crescents was similar in
all groups. In patients with MPO-ANCA positivity, inter-in 83% of biopsies and in approximately half of those
cases it was scored as diffuse (). Tubular casts and stitial fibrosis (Fig. 3B) and tubular atrophy (Fig. 3C)
were more frequently and more severely present thantubular necrosis were present in 87% and 66% of biop-
sies, respectively. Tubular atrophy was present in 86% in patients with PR3-ANCA positivity (P  0.008 and
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Fig. 1. Histopathological diagnoses on the
basis of the renal biopsy findings.
Table 4. Main glomerular lesions in MPA, RLV, and WG
MPA (N80) RLV (N19) WG (N73) P value
Lesions Mean SD Mean SD Mean SD MPA vs. RLV RLV vs. WG MPA vs. WG
Normal glomeruli 21 22 27 25 40 34 0.291 0.137 0.001
Fibrinoid necrosis 21 25 21 26 23 26 0.976 0.656 0.496
Crescentsa 47 28 49 33 42 32 0.790 0.365 0.257
Cellular crescents 45 28 55 27 45 29 0.210 0.205 0.902
Fibrous crescents 7 10 3 6 4 9 0.239 0.715 0.172
Glomerulosclerosis 30 29 23 25 16 23 0.361 0.265 0.002
Periglomerular infiltrates 10 16 16 20 9 12 0.121 0.033 0.680
Granulomatous reaction 4 13 2 6 2 8 0.566 0.918 0.379
a The mean percentage of cellular crescents and fibrous crescents together is usually different from the mean percentage of crescents, as the former two lesions
were not scored if crescents were absent
P  0.013, respectively). Tubular necrosis (Fig. 3E), tu- with MPO-ANCA versus patients with PR3-ANCA (data
not shown).bular intra-epithelial infiltrates (Fig. 3F), and arterioscle-
rosis were more frequently present in patients with
Sample sizeMPO-ANCA than in patients with PR3-ANCA (P 
0.030, P 0.006, and P 0.027, respectively). The histo- Reported results are based on analyses without a mini-
pathology in the group of patients with negative ELISA mum for the number of glomeruli in the biopsies (biop-
test results was more or less similar to that of MPO- sies without cortical tissue were excluded). We tested
ANCA positive patients (Table 5 and Fig. 3). It is ques- whether the presence of only a small number of glomer-
tionable whether these results are independent of the uli—less than five and less than ten—would influence
diagnostic subgroup. To address this issue, we tested our results, but this was not the case (data not shown).
whether ANCA specificity influenced renal histology in-
dependently of diagnosis. The observed differences in
DISCUSSIONthe occurrence of tubular necrosis (P 0.021) and tubu-
We present the results of a prospective multicenterlar intra-epithelial infiltrates (P 0.005) between MPO-
study of 173 renal biopsies from a homogeneous groupANCA and PR3-ANCA positive patients remained sig-
of patients with newly diagnosed renal disease in relationnificant after this correction. No differences between the
to ANCA-associated vasculitis. Our aim was to deter-groups were observed in the occurrence of interstitial
mine (1) the differences in the occurrence of renal histo-vasculitis. We also investigated the distribution patterns
logical lesions in microscopic polyangiitis, Wegener’sof histological features in patients with P-ANCA versus
granulomatosis, and renal limited vasculitis; and (2) thepatients with C-ANCA, and of P- and MPO-ANCA–
differences in the occurrence of renal histological lesionspositive patients versus C- and PR3-ANCA–positive pa-
in patients with ANCA-associated vasculitis with varioustients. Results of these analyses were similar to the above-
described histological distribution patterns in patients ANCA test results.
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Fig. 2. Renal histology in patients with microscopic polyangiitis, renal limited vasculitis, or Wegener’s granulomatosis. Differences in presence of
glomerular lesions (A), interstitial fibrosis (B), tubular atrophy (C ), interstitial infiltrates (D), tubular necrosis (E), and tubular intra-epithelial
infiltrates (F ), between the diagnostic categories are presented. Symbols in panel A are: () other; ( ) sclerosis; ( ) crescents; ( ) normal
glomeruli. Symbols in panels B and C are: ( ) diffuse; ( ) focal; ( ) absent. Panel D symbols are: () very dense; ( ) dense; ( ) mild; ( )
absent. Symbols in panels E and F are: ( ) present; ( ) absent.
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Table 5. Main glomerular lesions in patients with MPO-ANCA, PR3-ANCA, double positivity, and negative ELISA
MPO- &
Negative MPO- PR3- PR3-
ELISA ANCA ANCA ANCA
(N15) (N58) (N63) (N5)
P valueb
Negative vs. Negative vs. MPO-ANCA vs.
Lesions Mean SD Mean SD Mean SD Mean SD MPO-ANCA PR3-ANCA PR3-ANCA
Normal glomeruli 20 31 26 23 31 30 29 37 0.402 0.188 0.265
Fibrinoid necrosis 19 22 23 23 24 27 32 41 0.510 0.529 0.925
Crescentsa 45 32 47 26 50 32 70 37 0.766 0.525 0.514
Cellular crescents 46 29 46 24 50 30 70 37 0.907 0.671 0.357
Fibrous crescents 5 9 6 10 6 9 0 0 0.776 0.836 0.880
Glomerulosclerosis 35 34 25 26 15 21 1 2 0.222 0.005 0.022
Periglomerular infiltrates 8 11 11 18 8 12 16 18 0.554 0.901 0.219
Granulomatous reaction 1 3 5 15 1 4 0 0 0.401 0.969 0.092
a The mean percentage of cellular crescents and fibrous crescents together is usually different from the mean percentage of crescents as the
former two lesions were not scored if crescents were absent
b P values of negative, MPO-ANCA, and PR3-ANCA vs. MPO-ANCA positivity are not reported (in general, P values were over 0.100)
Glomerulosclerosis, interstitial fibrosis, tubular atro- ing for the GFR), but no significant differences were
observed (data not shown).phy, tubular casts, and arteriosclerosis occurred more
often and more pronounced in microscopic polyangiitis In this study, ANCA positivity was present in 149 of
164 patients in which ANCA test results were reported.and renal limited vasculitis than in Wegener’s granulo-
matosis. However, none of these lesions were specific for Patients with MPO-ANCA had significantly more glo-
merulosclerosis, interstitial fibrosis, tubular atrophy, andone of the diagnostic subgroups, which limits the role of
renal histopathology in further sub-categorizing ANCA- arteriosclerosis, but also significantly more tubular ne-
crosis and tubular intra-epithelial infiltrates. In otherassociated vasculitis. Except for tubular casts, the above-
mentioned lesions are representative of a chronic disease words, a mixture of both chronic and active lesions was
more abundantly present in patients with MPO-ANCAphase, reflecting the result of longer existing inflamma-
tion of the kidney, in which irreversible scars develop. than in patients with PR3-ANCA. The observed differ-
ences between the occurrence of tubular necrosis andSo-called active lesions (such as tubular intra-epithelial
infiltrates and glomerular crescents) did not discriminate tubular intra-epithelial infiltrates remained significant
after correction for diagnosis. One should realize, how-between the three diagnostic subgroups. We believe that
the explanation for these results is that in patients with ever, that the observed differences are small, that none
of the lesions is specific for one of the groups, and thatmicroscopic polyangiitis and renal limited vasculitis, the
diagnosis is established later than in patients with Weg- active glomerular lesions (that is, fibrinoid necrosis and
cellular crescents) were present to the same extent. Ourener’s granulomatosis. In over 90% of cases, Wegener’s
granulomatosis presents with upper airway or pulmonary results may be explained by the finding that circulating
soluble MPO, released by activated polymorphonucle-symptoms, or both [13], which probably reduces the pa-
tient’s and doctor’s delay. Alternatively, although such ars, may bind to resting “innocent bystander polymor-
phonuclears,” thereby making them reactive to anti-a mechanism is not known in vasculitis, our results could
also indicate that, at the same time point after onset of MPO antibodies, which leads to perpetuating inflamma-
tion and tissue destruction [14]. In addition, anti-MPOthe disease, patients with renal limited vasculitis and
with microscopic polyangiitis may have developed more antibodies may inhibit the inactivation of MPO by ceru-
loplasmin, its natural inhibitor [15], resulting in persis-irreversible lesions in the kidney than patients with Weg-
ener’s granulomatosis. This may be explained by a faster tent generation of reactive oxygen radicals with en-
hanced potential for endothelial cytotoxicity [16]. Theseprogression of active lesions to chronic lesions in micro-
scopic polyangiitis and renal limited vasculitis or, alterna- processes may lead to a more active disease, and in
the long term, to more chronic damage in MPO-ANCAtively, by development of chronic lesions without the
obligatory presence of active lesions. An argument in positive patients than in PR3-ANCA-positive patients.
The previously reported tendency to a more frequentfavor of the occurrence of the latter mechanisms would
be that, after correction for the diagnostic delay, the renal involvement in patients with MPO-ANCA than
in patients with PR3-ANCA is further evidence for aobserved differences in renal histology between the diag-
noses are still present. Therefore, we re-analyzed our stronger renal pathogenic effect of MPO-ANCA com-
pared to PR3-ANCA [12, 17].results by correcting for the diagnostic delay (by correct-
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Fig. 3. Renal histology in patients with PR3-ANCA, MPO-ANCA, PR3- and MPO-ANCA, or negative ELISA. Differences in presence of
glomerular lesions (A), interstitial fibrosis (B), tubular atrophy (C ), interstitial infiltrates (D), tubular necrosis (E), and tubular intra-epithelial
infiltrates (F ) between the ELISA test result groups are illustrated. Symbols in panel A are: () other; ( ) sclerosis; ( ) crescents; ( ) normal
glomeruli. Symbols in panels B and C are: ( ) diffuse; ( ) focal; ( ) absent. Panel D symbols are: () very dense; ( ) dense; ( ) mild; ( )
absent. Symbols in panels E and F are: ( ) present; ( ) absent.
Previous investigations on the occurrence of renal his- in a retrospective analysis of 36 patients with ANCA-
associated vasculitis, that patients with PR3-ANCA posi-topathological differences between patients with MPO-
ANCA and PR3-ANCA led to contradictory results. In tivity had more fibrinoid necrosis and a higher activity
index than MPO-ANCA positive patients, and that pa-three reports, no differences between these groups were
found (abstract; ibid) [7, 8]. Franssen et al described tients with MPO-ANCA had more glomerulosclerosis
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P. Landais (Hoˆpital Necker, Paris, France), Ph. Vanhille (Centre Hospi-and a higher chronicity index [9], which may be explained
talier de Valenciennes, Valenciennes, France), P. Bataille (Centre Hospi-
by the inhibitory effect by PR3-ANCA binding to PR3 talier General, Bologne sur Mer, France), V. Esnault (CHU Hotel Dieu,
on the irreversible inactivation of PR3 by 1-antitrypsin Nantes, France), F. van der Woude, R. Waldherr, W. Schmitt, K. An-
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Hospital Groningen, Groningen, The Netherlands), C.D. Kooijmanbe an argument in favor of the existence of different
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(Hospital Clinic I Provincial de Barcelona, Barcelona, Spain), F. Algaba
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